AU2002234053A1 - Lentiviral vector-mediated gene transfer and uses thereof - Google Patents

Lentiviral vector-mediated gene transfer and uses thereof

Info

Publication number
AU2002234053A1
AU2002234053A1 AU2002234053A AU2002234053A AU2002234053A1 AU 2002234053 A1 AU2002234053 A1 AU 2002234053A1 AU 2002234053 A AU2002234053 A AU 2002234053A AU 2002234053 A AU2002234053 A AU 2002234053A AU 2002234053 A1 AU2002234053 A1 AU 2002234053A1
Authority
AU
Australia
Prior art keywords
gene transfer
lentiviral vector
mediated gene
mediated
lentiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002234053A
Other versions
AU2002234053B2 (en
Inventor
Binoy Appukuttan
J. Timothy Stout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Priority claimed from PCT/US2001/049241 external-priority patent/WO2002049677A1/en
Publication of AU2002234053A1 publication Critical patent/AU2002234053A1/en
Application granted granted Critical
Publication of AU2002234053B2 publication Critical patent/AU2002234053B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002234053A 2000-12-19 2001-12-18 Lentiviral vector-mediated gene transfer and uses thereof Ceased AU2002234053B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25670100P 2000-12-19 2000-12-19
US60/256,701 2000-12-19
PCT/US2001/049241 WO2002049677A1 (en) 2000-12-19 2001-12-18 Lentiviral vector-mediated gene transfer and uses thereof

Publications (2)

Publication Number Publication Date
AU2002234053A1 true AU2002234053A1 (en) 2002-09-05
AU2002234053B2 AU2002234053B2 (en) 2004-07-15

Family

ID=22973247

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002234053A Ceased AU2002234053B2 (en) 2000-12-19 2001-12-18 Lentiviral vector-mediated gene transfer and uses thereof
AU3405302A Pending AU3405302A (en) 2000-12-19 2001-12-18 Lentiviral vector-mediated gene transfer and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU3405302A Pending AU3405302A (en) 2000-12-19 2001-12-18 Lentiviral vector-mediated gene transfer and uses thereof

Country Status (15)

Country Link
US (1) US20020114783A1 (en)
EP (2) EP1343532B1 (en)
JP (2) JP4280496B2 (en)
KR (3) KR20080080684A (en)
CN (2) CN101732731B (en)
AU (2) AU2002234053B2 (en)
CA (1) CA2432301C (en)
DK (2) DK1343532T3 (en)
ES (2) ES2422301T3 (en)
IL (2) IL156427A0 (en)
NZ (1) NZ526558A (en)
PT (2) PT2301583E (en)
RU (1) RU2288742C2 (en)
WO (1) WO2002049677A1 (en)
ZA (1) ZA200304664B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080080684A (en) * 2000-12-19 2008-09-04 리서치 디벨럽먼트 파운데이션 Lentiviral vector-mediated gene transfer and composition therefor
US7122181B2 (en) * 2000-12-19 2006-10-17 Research Development Foundation Lentiviral vector-mediated gene transfer and uses thereof
JP4689144B2 (en) 2001-02-22 2011-05-25 ノバルティス アーゲー Methods for treating ocular neovascularization
AU2003277910A1 (en) * 2002-09-27 2004-04-19 Novartis Ag Ocular gene therapy
US7601341B2 (en) * 2003-06-05 2009-10-13 Research Development Foundation Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis
US20060259997A1 (en) * 2003-08-29 2006-11-16 Shinji Iijima Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
EP1881849A2 (en) * 2005-04-29 2008-01-30 Research Development Foundation Vascular targeting of ocular neovascularization
WO2008044339A1 (en) * 2006-10-13 2008-04-17 Aqumen Biopharmaceuticals K.K. Therapeutic/preventive agent for intraocular disease containing statin compound
CN101870734B (en) * 2010-05-25 2012-06-20 北京大学 Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
RU2444734C1 (en) * 2010-11-03 2012-03-10 ФГУ Ростовский НИИ акушерства и педиатрии Министерства по здравоохранению и социальному развитию РФ Method for prediction of early infectious miscarriage
CA2940765A1 (en) 2014-02-25 2015-09-03 Research Development Foundation Sty peptides for inhibition of angiogenesis
US11206977B2 (en) 2014-11-09 2021-12-28 The Trustees Of The University Of Pennyslvania Vision test for determining retinal disease progression
GB2547179A (en) * 2015-10-26 2017-08-16 Quethera Ltd Genetic construct
CN111398595A (en) * 2020-02-17 2020-07-10 天津医科大学眼科医院 Application and detection method of protein TNFAIP8 in plasma small cell outer vesicle

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
US5871723A (en) * 1995-06-06 1999-02-16 The Regent Of The University Of Michigan CXC chemokines as regulators of angiogenesis
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
ES2246513T3 (en) * 1996-05-03 2006-02-16 Abbott Laboratories NEW ANTI-ANGIOGENIC, POLINUCLEOTID PEPTIDES CODING THEM AND ANGIOGENESIS INHIBITION PROCEDURES.
US6004798A (en) * 1997-05-14 1999-12-21 University Of Southern California Retroviral envelopes having modified hypervariable polyproline regions
JPH1180024A (en) * 1997-09-12 1999-03-23 Toagosei Co Ltd Corneal vascular rebirth inhibitor
CA2367375A1 (en) * 1999-03-15 2000-09-21 Chiron Corporation Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
KR20080080684A (en) * 2000-12-19 2008-09-04 리서치 디벨럽먼트 파운데이션 Lentiviral vector-mediated gene transfer and composition therefor

Similar Documents

Publication Publication Date Title
AU3369900A (en) Gene silencing
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002234053A1 (en) Lentiviral vector-mediated gene transfer and uses thereof
AU3405302A (en) Lentiviral vector-mediated gene transfer and uses thereof
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU2002237240A1 (en) Histone deacetylase-related gene and protein
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU5245900A (en) Novel protein and dna thereof
AU2001242625A1 (en) Gene sequence
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
AU2001264247A1 (en) GASC1 gene
AU2001274566A1 (en) Novel protein and dna thereof
AU2001264488A1 (en) Gene expression cassette and its use
AUPQ749100A0 (en) New epilespy gene
AU2001247444A1 (en) Erbeta-mediated gene expression
AU1894601A (en) Novel gene and use thereof
AU2001285743A1 (en) Adipose-related gene
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2225401A (en) Novel protein and dna thereof
AU2001274563A1 (en) Novel polypeptide and its dna
AU2002246758A1 (en) Epididymal lipocalin gene and uses thereof
AU2001286120A1 (en) Interferon-alpha induced gene
AU2002222187A1 (en) Interferon-alpha induced gene